Biofidelity

Biofidelity and CellCarta partner to deploy Aspyre Lung in global clinical trials

9 January 2025 -- Cambridge, UK and Montreal, Canada -- Biofidelity, a leader in innovative genomic solutions, and CellCarta, the global contract research organization (CRO) partner of choice for biopharmaceutical companies seeking precision medicine solutions, today announced a strategic partnership agreement to utilize Biofidelity’s Aspyre® Lung in global clinical trials. Aspyre Lung simplifies the detection...
5151 McCrimmon Parkway, Suite 230 Morrisville, NC 27560

+1 919 659 3285